Holiday vacation time

Folks, we'll be closed for the holiday and won't publish between Christmas and New Year's. FierceBiotechResearch will return to its regular publishing schedule on Tuesday Jan. 3, 2012. In the interim, send your news to me at [email protected] or @MarkHFierce on Twitter. Happy Holidays, everyone. - Mark Hollmer (twitter | email)

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.